HOME >> BIOLOGY >> NEWS
UCSF Comprehensive Cancer Center program triumphs

UCSF Comprehensive Cancer Center basic scientists and clinical researchers have received a highly coveted grant from the National Cancer Institute that they say will fuel their ongoing mission to methodically and aggressively move in on prostate cancer.

The $11.9 million five-year grant, with an additional $12 million in matching funds raised by an advocacy group led by Andy Grove, co-founder and chairman of Intel Corp., is designed to drive a cross pollination of ideas between some of the world's leading basic scientists and clinical researchers to improve prostate cancer treatment, early detection and prevention. First year funding is $2.3 million.

The so-called SPORE grant, for Specialized Program of Research Excellence, is unique, as most major basic science grants do not include funding for clinical research. The grant was awarded to UCSF in recognition of the breadth and depth of the UCSF Comprehensive Cancer Center's basic science and clinical research programs and its ability to integrate these programs for clinical advance.

"Our goal with this SPORE is to take a fresh approach to trying to solve the significant problems in prostate cancer research," says Marc A. Shuman, MD, professor of medicine and director of the new UCSF Prostate SPORE. "We intentionally sought out outstanding basic scientists who, while not already studying this disease were interested in changing a significant part of their effort to work on these problems, and would make a commitment to working closely with prostate cancer clinicians and clinical scientists.

"Scientists can do great things when they work on a project on their own, but the most successful strategy for disease-related research is the team approach, where you integrate successful people representing different specialties," says Shuman. And the outcome to such cross pollination is more than additive, he says. "There's a synergism."

The decision to apply for a prostate SPORE grew out of a prostate
'"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
15-Oct-2000


Page: 1 2 3 4 5

Related biology news :

1. Comprehensive study: We know little about environmental effects on kids
2. Comprehensive set of vision genes discovered: Identification could help in diagnosing and treating blinding diseases
3. National Cancer Institute designates Vanderbilt-Ingram a Comprehensive Cancer Center
4. Endangered Species Recovery Plans Face Comprehensive Scientific Review
5. Web Site Offers Comprehensive Information On Mad Cow Disease
6. Comprehensive Nutritional Status In Patients With Long-Standing Crohn Disease Currently In Remission
7. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
8. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
9. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10. Cancer gene MYC emerging as key research target
11. Cancer patient, heal thyself

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in Regenerative ... Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... effective way to complete one? Will the study comply with all FDA requirements? ...
(Date:7/2/2020)... ... July 01, 2020 , ... ... phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute ... Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... N.C. (PRWEB) , ... June 29, 2020 , ... ... reported year to date growth of 40% in 2020, despite many obstacles created ... technology, MedShift aims to increase revenue for its partnered medical practices and medical ...
(Date:7/1/2020)... Colo. (PRWEB) , ... June ... ... of expert tissue data insights, today announced that the launch of a ... results along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the ... vaccine or drug treatment. In an effort to better understand the cellular responses ... world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 approved and ...
Breaking Biology Technology:
Cached News: